October 12, 2016
  • Statins Remain First-Line Therapy, But Nonstatins Also Effective

    Statins are the preferred agent for lowering low-density lipoprotein cholesterol and reducing the risk of cardiovascular events, according to a new review. Study authors suggest, however, that other interventions, especially those that act predominantly through upregulation of LDL receptor expression, might provide additional options.

  • Opposition to Pharmacy Substitution Is One Barrier to Broader Biosimilar Use

    Despite FDA-approved biosimilars in the U.S. market, the products are not used here as often as in some European countries, according to a new survey. Find out how unwillingness to allow pharmacy-level substitution is a factor.

  • Endocrine Society Pushes for Continuous Glucose Monitor Use in T1D Patients
    New guidelines issued by the Endocrine Society make a big push for broader use of continuous glucose monitors in adult type 1 diabetes patients. The problem, according to study authors, is that Medicare doesn’t cover the technology. Here is more information.
  • H1N1 Vaccination in Pregnancy Doesn’t Increase Congenital Malformation

    Some new information should help pharmacists soothe the fears of expectant mothers about possible adverse effects in the fetus related to H1N1 influenza vaccine. A large new study finds that the flu vaccine has no effect on the risk of congenital malformation when familial factors are taken into account. Here are the details.


Connect With U.S. Pharmacist
USP Google AppUSP Itunes App